Skin Extra-intestinal Manifestations
1 clinical trials · Condition
◉ Watch Skin Extra-intestinal Manifestations
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations (NCT03139032) | Arena Pharmaceuticals | 2017-07-17 |
Track Skin Extra-intestinal Manifestations automatically
Every clearance here is in the API, with alerts when new ones post.